<DOC>
	<DOCNO>NCT00202462</DOCNO>
	<brief_summary>We hypothesize testosterone replacement improve mood quality life old men low testosterone mild depression . Study subject receive either testosterone gel placebo ( inactive ) gel 12 week . Neither subject investigator know whether receive placebo testosterone gel . At end initial 12 week period , subject receive testosterone gel 12 week . Mood quality life measure obtain baseline , end double-blind phase end extension phase ( subject receive testosterone . )</brief_summary>
	<brief_title>The Effect Testosterone Mood Quality Life</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled trial testosterone replacement old men age-associated hypogonadism subsyndromal depression . Men receive either 7.5 gm/qd testosterone gel placebo gel 12 week . The double-blind phase follow 12 week open-label extension subject receive 7.5 gm/qd testosterone gel . Procedures : Depressive symptom assess Hamilton Depression Rating Scale ( HDRS ) SCL-20 , 20-item self-report depression scale show high reliability validity sensitive change depressive symptom outpatient primary care setting . The short form ( 16 item ) Endicott Quality Life Enjoyment Satisfaction Scale use assess quality life change . The Medical Outcomes Study Short-Form 36 ( SF-36 ) use assess change functional status . Demographic information , medical history current medication determine baseline follow , via patient interview chart review . Overall medical morbidity ascertain Cumulative Illness Rating Scale . All outcome measure ( SCL-20 , Endicott Quality Life Scale , HDRS , SF-36 ) assess baseline , week 12 ( end double-blind phase ) week 24 ( end extension phase ) . Blood draw do baseline , week 12 week 24 . Laboratory assay testosterone leves baseline , week 12 week 24 perform time minimize interassay variability .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Gonadal Disorders</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Age : 50 old Total Testosterone &lt; =280 ng/dl Subsyndromal depressive disorder : either dysthymia minor depression ( per DSM IV DSM IV appendix ) PSA &gt; =3.0 Klinefelter 's syndrome Prostate breast cancer Hospitalized past month Obstructive BPH Current testosterone treatment Schizophrenia , bipolar disorder , dementia Treatment antipsychotic benzodiazepine Alcohol dependence substance dependence Suicidal psychotic symptom</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>testosterone</keyword>
	<keyword>depression</keyword>
	<keyword>subsyndromal depression</keyword>
	<keyword>quality life</keyword>
</DOC>